SCHEMBL30682062

SCHEMBL30682062

CS(=O)(=O)c1cccc(NC(=O)c2cc3cnccc3nc2N2CCCC(F)(F)CC2)c1

nearest known ligand 0.56

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ SCN10A Q9Y5Y9 14/20 0.56
▸ KIF18A Q8NI77 6/20 0.53
▸ NR1I2 O75469 1/20 0.51
▸ CACNA1C Q13936 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26617475 1.00 SCN10A (0.56) SCN10AKIF18ANR1I2CACNA1C
SCHEMBL30681962 0.94 SCN10A (0.56) SCN10AKIF18ANR1I2CACNA1C
SCHEMBL26617714 0.94 SCN10A (0.56) SCN10AKIF18ANR1I2CACNA1C
SCHEMBL26617595 0.94 SCN10A (0.56) SCN10AKIF18ANR1I2CACNA1C
SCHEMBL30681923 0.94 SCN10A (0.56) SCN10AKIF18ANR1I2CACNA1C
SCHEMBL30681999 0.92 SCN10A (0.67) SCN10ANR1I2CACNA1C
SCHEMBL26617591 0.92 SCN10A (0.67) SCN10ANR1I2CACNA1C
SCHEMBL30681908 0.88 SCN10A (0.56) SCN10AKIF18ANR1I2CACNA1C
SCHEMBL26618100 0.88 SCN10A (0.56) SCN10AKIF18ANR1I2CACNA1C
SCHEMBL30681996 0.86 SCN10A (0.49) SCN10AKIF18A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119585247-A Bicyclic heterocyclic amide inhibitors of nav1.8 for the treatment of pain 赛特温治疗公司 2025-03-07 — — CN disclosed
EP-4514789-A1 <SUP2/>? <SUB2/>?V?BICYCLIC HETEROCYCLIC AMIDE INHIBITORS OF NA1.8 FOR THE TREATMENT OF PAIN SiteOne Therapeutics, Inc. (US) 2025-03-05 — — EP disclosed
WO-2023211990-A1 BICYCLIC HETEROCYCLIC AMIDE INHIBITORS OF NA V1.8 FOR THE TREATMENT OF PAIN SITEONE THERAPEUTICS, INC. (US) 2023-11-02 — — WO disclosed
Send feedback